Drug-free sustained remission or spontaneous remission by natural history in rheumatoid arthritis? An unsolved question: comment on the article of Ajeganova et al

被引：6
|
作者：
Zeidler, Henning [1 ]
机构：
[1] Hannover Med Sch, Dept Immunol & Rheumatol, Carl Neuberg Str 1, D-30625 Hannover, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷 / 07期
关键词：
CLASSIFICATION CRITERIA;
D O I：
10.1136/annrheumdis-2016-210887
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] On Drug and Drug-Free Remission By Baseline Disease Duration: Abatacept Versus Methotrexate Comparison in Patients with Early Rheumatoid Arthritis
    Bykerk, V. P.
    Burmester, Gerd
    Combe, B. G.
    Furst, Daniel E.
    Huizinga, T. W. J.
    Wong, D. A.
    Emery, Paul
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [32] Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis
    Vivian P. Bykerk
    Gerd R. Burmester
    Bernard G. Combe
    Daniel E. Furst
    Tom W. J. Huizinga
    Harris A. Ahmad
    Paul Emery
    Rheumatology International, 2019, 39 : 945 - 945
  • [33] Can rheumatoid arthritis ever cease to exist: a review of various therapeutic modalities to maintain drug-free remission?
    Liu, Di
    Yuan, Na
    Yu, Guimei
    Song, Ge
    Chen, Yan
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2017, 9 (08): : 3758 - 3775
  • [34] Improved outcomes of drug-free remission with DAS-steered therapy compared to conventional therapy for rheumatoid arthritis
    van der Woude, D.
    Visser, K.
    Brand, R.
    Klarenbeek, N. B.
    van der Linden, M. P. M.
    Mailee, C.
    de Beus, W. M.
    Kerstens, P. J. S. M.
    Dijkmans, B. A. C.
    Huizinga, T. W. J.
    Mil, A. H. M. van der Helm-van
    Allaart, C. F.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S919 - S920
  • [35] Predicting drug-free remission in rheumatoid arthritis: A prospective interventional cohort study (vol 105, 102298, 2019)
    Baker, Kenneth F.
    Skelton, Andrew J.
    Lendrem, Dennis W.
    Scadeng, Adam
    Thompson, Ben
    Pratt, Arthur G.
    Isaacs, John D.
    JOURNAL OF AUTOIMMUNITY, 2022, 132
  • [36] Sustained drug-free remission in rheumatoid arthritis after DAS-driven or non-DAS-driven therapy: a comparison of two cohort studies
    van der Woude, Diane
    Visser, Karen
    Klarenbeek, Naomi B.
    Ronday, H. Karel
    Peeters, Andre J.
    Kerstens, Pit J. S. M.
    Dijkmans, Ben A. C.
    Huizinga, Tom W. J.
    van der Helm-van Mil, Annette H. M.
    Allaart, Cornelia F.
    RHEUMATOLOGY, 2012, 51 (06) : 1120 - 1128
  • [37] Response to: 'Correspondence on 'Tapering towards DMARD-free remission in rheumatoid arthritis' by Garcia et al
    van Mulligen, Elise
    de Jong, Pascal Hendrik Pieter
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (01)
  • [38] PREDICTION OF SUSTAINED BIOLOGIC AND TARGETED SYNTHETIC DISEASE MODIFYING ANTIRHEUMATIC DRUG FREE REMISSION IN RHEUMATOID ARTHRITIS PATIENTS
    Burkard, T.
    Williams, R. D.
    Vallejo-Yague, E.
    Hugle, T.
    Finkch, A.
    Kyburz, D.
    Burden, A. M.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S333 - S333
  • [39] ON DRUG AND DRUG-FREE REMISSION BY BASELINE DISEASE DURATION IN THE AVERT TRIAL: ABATACEPT VERSUS METHOTREXATE COMPARISON IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
    Bykerk, V. P.
    Burmester, G. R.
    Combe, B. G.
    Furst, D. E.
    Huizinga, T. W. J.
    Wong, D. A.
    Emery, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 477 - 478
  • [40] ON DRUG AND DRUG-FREE REMISSION BY BASELINE DISEASE DURATION IN THE AVERT TRIAL: ABATACEPT VERSUS METHOTREXATE COMPARISON IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
    Bykerk, Vivian
    Burmester, Gerd
    Combe, Bernard
    Furst, Daniel E.
    Huizinga, Tom
    Wong, Daniel
    Emery, Paul
    RHEUMATOLOGY, 2016, 55 : 97 - 98
12345